Anpario (LON:ANP) Price Target Raised to GBX 570

Anpario (LON:ANP) had its target price upped by Canaccord Genuity Group from GBX 550 to GBX 570 in a research report sent to investors on Thursday, Marketbeat reports. The brokerage currently has a buy rating on the stock.

Separately, Shore Capital reaffirmed a “house stock” rating on shares of Anpario in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of GBX 570.

Anpario Stock Performance

Anpario stock opened at GBX 550 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The company has a market capitalization of £93.20 million, a price-to-earnings ratio of 18.51 and a beta of 0.58. Anpario has a fifty-two week low of GBX 286 and a fifty-two week high of GBX 570. The stock has a fifty day moving average of GBX 489.46 and a two-hundred day moving average of GBX 462.13.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.